Webinar 3 Never bet against equity markets in the long-run

Equity experts at UBS Asset Management told investors in a webinar. What metrics are they looking at to find companies that will survive the crisis successfully?

14 Apr 2020

The surge in equity market volatility during the current COVID-19 crisis is indicative of the overwhelming uncertainty and fear investors are feeling. This environment creates tremendous opportunities, but diligence and adherence to a well-defined investment process is key. In this market, there is no substitute for seasoned judgement and experience.

Ian McIntosh, Head of Active Equities, Peter J. Bye, Head of US Growth Equities, and Max Anderl, Head of Concentrated Alpha Equity, spoke to investors about the way forward in equity markets.

Key takeaways for equity investing in the long-run

  • The equity market downturn during the first quarter was one of the quickest sell-offs in history and has resulted in wide price differentials between different stocks and sectors. This creates investment opportunities for active investors.
  • While there remains a high degree of uncertainty, the pathway to a recovery from the pandemic is beginning to take form. If the economy is able to gradually begin opening back up within the next two months we should see a quicker recovery. Markets have started to recover from very depressed levels and Equities should continue to provide strong long term returns
  • We believe that many business sectors at the 'epicenter' of the downturn will be the slowest to recover. In this case, we believe consumer services will take longer to recover.
  • The social distancing measures put in place to slow the spread of the coronavirus have accelerated some ongoing trends which will create winners and losers.
  • We expect companies involved in cashless payments, online shopping and virtual or remote work will do well during the recovery, while department stores and travel related businesses will have more trouble.

Equity investing Long-term consensus is bullish for equity markets

Ian McIntosh, Head of Active Equities

The equity market downturn during the first quarter was truly shocking, one of the quickest sell-offs in equity market history. In the US, this resulted in a 20% performance differential between small-cap and large-cap stocks.

One explanation may be that small-cap companies tend to have much more leverage; more so in the US than in Europe. 

The valuation dispersion from the cheapest quintile of the market to the most expensive is higher than during either the 2000 tech bubble or the 2008-2009 Financial Crisis.

The speed at which valuation spreads widened over the last month was remarkable. This underscores the headwinds that currently exist for value investors, and also the opportunity on a forward looking basis.

Our base case for equity investing

The roadmap to recovery from the current crisis has three phases. Phase 1, which we are in now, is slowing the spread of COVID-19. Phase 2 is the gradual reopening of the economy and the relaxation of controls. The final phase is relaxing controls completely, once a vaccine is available.

Our base case at this stage is that we'll see a movement to the gradual reopening of the US economy in the next 2 months. Equities have provided positive long term returns over all rolling ten year periods, and setbacks have provided good entry points, as we believe to be the case this time.

Equity investing Where to invest for the recovery

Maximilian Anderl, Head of Concentrated Alpha Equity

One example of how a recovery might look is already here, as recovery is already underway in China.

Economic activity there, which generally drops during the Chinese New Year, usually bounces right back after the festivities end.

The New Year drop was substantially prolonged this year due to the pandemic, but as China gets the virus under control, the economy has begun to come back, with about 80% of sectors recovering relatively quickly. The other 20% will take some time.

We see signs that the crisis has accelerated trends that already existed, which has implications for investors. 

The movements from offline to online services, shopping and cashless payments are getting a boost as more people were forced to move to digital providers during the pandemic. The success of remote work may slow the recovery of travel-related sectors.

For investors who are absolute return, lower risk oriented consumer staples and healthcare will offer yields and we think these companies will perform better than cash and bonds. On the more risk-taking side that seeks to outperform benchmarks, we consider quality cyclicals that have been hit hard as worth considering, from semiconductor equipment to software providers and cloud operators, healthcare equipment.

We also see opportunities in value but prefer operationally geared companies to financially geared companies, which means cyclical characteristic companies with either a good balance sheet or that are very stable. New facets of sustainability, in terms of self-sustainability, medication, drugs, masks, etc. will become more important going forward.

The 'epicenter' of this crisis is concentrated in the service sector, which historically is more stable, but which is being hit hard by social distancing measures.

Small business owners and the self-employed, such as dentists, lawyers, coffee shops, and restaurants for example are hit the hardest. But the positive to this crisis is the support from central banks, which has come very early compared to the Financial Crisis of 2008-2009 and amounts to about 3% of global GDP, much of it aimed at small business.

The increase in commercial loans is one example of the extraordinary support. We do not think this time we will have the same systemic consequences, unlike during the Financial Crisis.

Equity investing Avoid the crisis epicentre

Peter J. Bye, Portfolio Manager / Senior Investment Analyst

There are a myriad of forms this crisis and recovery can take, and we need to understand how each of them can play out. Investors can learn valuable lessons from former US Defense Secretary Donald Rumsfeld's famous comment about how his team examined intelligence, "There are known knowns. There are things we know we know. We also know there are known unknowns. That is to say, we know there are some things we do not know. But there are also unknown unknowns, the ones we don't know we don't know."

Among the 'known knowns,' are the lessons we learned from previous crises. One big lesson is to avoid the 'epicenter' of the crisis. After the 2000 tech bubble, it took 15 years for tech stocks to revert back to their 2000 highs.

But within that segment, quality growth names were much quicker to recover. We saw the same pattern with financial stocks, the epicenter of the Financial Crisis of 2008-2009. Financial ETFs recovered their pre-crisis level just last year, but even within financials, some did much better than others.

In this crisis, the consumer segment is most exposed and appears to be the epicenter, though that could evolve into financial and some part of industrials, depending on the duration of the crisis. And again, we expect some areas within the epicenter to recover more quickly than others. 

How are we approaching the current crisis?

We use a similar approach to dealing with any market crisis. Our first job is to quantify the 'knowns' and 'unknowns,' using a variety of data in addition to financials.

For example, real time data ranging from web traffic to credit card transactions from our Quantitative Evidence and Data Science team has been helpful in giving us a clearer picture of what is changing, and to determine which changes are transitory and which are secular.

We see remote working, e-commerce, telemedicine as secular changes that were already happening but are accelerating due to the crisis. This helps us develop the opportunity set, while being mindful of following our core investment process.

In times of uncertainty, always be mindful of keeping sight of your process. What are good returns? What has a defensible model? What is sustainable? What is substitutable and what is essential? Those are the kinds of things we are dialing in on.

Singapore Retail Investors


This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2021 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.


4 equity investing themes in the post COVID-19 world

  • Digital transformation. This was a top corporate priority before the crisis and will emerge as an even stronger priority. This includes cloud infrastructure and e-commerce.
  • Health care. This includes biotech, medical technologies and laboratory research. So-called 'elective' medical procedures such as cosmetic surgery will resume and we see opportunities in oversold medical technologies.
  • Consumer. As the epicenter of the crisis, the recession will deal a critical blow to marginal players, but durable IP and brand power should allow some 'storied' companies to prosper.
  • Fintech. Companies connected to the digitization of money. For example, merchant acquirers and the trenches of the payment systems we see opportunities all around there.

Subscribe now

Perspectives matter. Tune in to our insights.


We are cash-flow based as well as scenario based. The business models that aim for grabbing market share and offer some innovation look promising, although profits may come later. We are cautious, because not all these businesses will make it. We look for those that are able, not necessarily to make a lot of profit today but to fund their own growth. Some of these are smaller companies. You need to have a certain moat around your business. That might be a license that nobody else can get, or a regulatory advantage. On the other side it's not helpful to produce something that is also offered by a big company, in IT for example, that will eventually push you out and can sustain losses longer than you can.

Another thing to think about is a V-shaped recovery. If this becomes a two-quarter zero earnings scenario and then we go back to where it was before, the biggest losers riding through here are going to be the biggest winners all the way back.

We also consider ESG, especially in terms of governance, how they do capital allocation, how they are treating their employees during the recession.

It's a combination of operationally and financially geared companies. We've seen the ones where credit spreads opened up, such as some in the energy sector where the market has to ask whether they can sustain this until we have a normalization, either from the virus or the oil price drop. The problem with these stocks is they are options, and when the time value is run out and the option is not in the money then you get nothing.

Department stores were already suffering before the current crisis. Now they are in lockdown while already facing the trend towards online shopping.

We prefer insurance businesses to banks, because banks by nature are the most financially and operationally geared companies because equity value or tier one ratio is relatively small compared to other industries, and we can see how often these banks, particularly in Europe have been drafted to do some social servicing, which is good and important, but from an investor's point of view, not so beneficial. Insurance businesses are fulfilling social functions as well but first the balance sheet is not that much on the fire, the equity positions are smaller, even the bond positions, some of that held by the opening up of the bond spread helps the solvency too in in some areas of the market.

We're all looking to value correctly. Using the traditional price to book value, I think over time there has been a trend towards an under-appreciation of what's on the balance sheet, and the ignoring of intangible value. Certainly, during the tech bubble there was an overestimation potentially of what those intangibles are worth but maybe now there's more of a normalization of what those intangibles are worth during this cycle, and an overestimation of what book value actually is. As an example, look at energy companies. What was book value when oil was at $80 a few years ago, versus book value as a fracker with at oil at $25?

We're always looking for value and it's the sum of the cash flows, so we're looking for durable sustainable businesses and lack of replacement options. We do think there's a lot of dynamic transition going on during this decade, which is also leading to some of the quote unquote disparity in underlying performance.

We expected companies to cut buyback activity, but we expected dividends to be more stable. Currently, 15% of the Eurostock 600 have cut dividends, in some cases as required by their regulator. It's a remarkably quick reaction. During the Financial Crisis, about one quarter of companies eliminated their dividend. This trend is far more subdued in US markets today.

One issue with dividend cuts is that small investors these days have turned from government bonds to equities for income and rely on dividend payments to maintain their lifestyles. If the company balance sheet supports it, I think it serves a social good for companies to continue paying dividends. Of course, if the stability isn't there, nothing could be worse than continuing the dividend.

The 'right' level of cash depends on several things that are impossible to forecast right now, such as will there be a second wave of the pandemic, will there be permanent immunity for those who have recovered, or will immunity only last for three or four months?

In our equity portfolios, generally we have a low target range for cash. We are not asset allocators. Initially, at the beginning of the downturn, we sold some holdings, but as the market continued to sink, we made some purchases. Then, during the 20% rally, we brought cash levels up to normal levels for our portfolio, which is a couple of percent.

More insights